Saturday, 18 August 2018

Zydus Cadila signs pact with IMTECH

05 July 2018 | News

The agreement has been signed to identify new drug candidates for treatment of drug resistant infections.

Image credit- quora.com

Image credit- quora.com

Zydus Cadila has inked an agreement with Council of Scientific and Industrial Research (CSIR) - Institute of Microbial Technology (IMTECH) to identify new drug candidates for treatment of drug resistant infections.

The collaborative research agreement will see scientists from both organisations working together on microbiology and genomics to identify new lead candidate as novel anti-tuberculosis compound.

For this project, scientists at IMTECH will utilise their expertise and scientific knowledge in microbiology while Zydus Cadila will provide expertise in medicinal chemistry and pharmaceutical drug development to develop new drug combinations against drug-resistant pathogens which causes severe diseases in India and across the world.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Will government's drug price caps trigger showdown with US?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls